Repro-Med Systems (REPR) & Merit Medical Systems (MMSI) Financial Review
Repro-Med Systems (OTCMKTS:REPR) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.
Institutional and Insider Ownership
17.7% of Repro-Med Systems shares are owned by institutional investors. Comparatively, 96.5% of Merit Medical Systems shares are owned by institutional investors. 40.0% of Repro-Med Systems shares are owned by company insiders. Comparatively, 4.8% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Repro-Med Systems has a beta of -0.79, meaning that its share price is 179% less volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500.
This table compares Repro-Med Systems and Merit Medical Systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Merit Medical Systems||4.68%||10.99%||6.50%|
This is a breakdown of current ratings and recommmendations for Repro-Med Systems and Merit Medical Systems, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Merit Medical Systems||1||0||8||0||2.78|
Merit Medical Systems has a consensus price target of $68.44, suggesting a potential upside of 27.60%. Given Merit Medical Systems’ higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Repro-Med Systems.
Earnings & Valuation
This table compares Repro-Med Systems and Merit Medical Systems’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Repro-Med Systems||$17.35 million||3.57||$910,000.00||N/A||N/A|
|Merit Medical Systems||$882.75 million||3.34||$42.02 million||$1.69||31.74|
Merit Medical Systems has higher revenue and earnings than Repro-Med Systems.
Merit Medical Systems beats Repro-Med Systems on 7 of the 11 factors compared between the two stocks.
About Repro-Med Systems
Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
About Merit Medical Systems
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions. The company also offers cardiovascular and critical care products to treat patients with life-threatening diseases, protect healthcare providers from exposure to bloodborne pathogens, and provide medical devices. In addition, it provides interventional oncology and spine products comprising delivery system, embolotherapy, spine ablation, and vertebral compression fracture products to treat metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, the company offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical system sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with MarketBeat.com's FREE daily email newsletter.